Summary of Product Characteristics
last updated on the eMC:
15/02/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15/02/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
-
Change to section 6.1 - List of Excipients
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 02/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
For further information, please contact GlaxoSmithKline on +44 (0)800 221 441
|
|
Updated on 04/04/2006 and displayed until 15/02/2007
|
Reasons for adding or updating:
|
-
Change to section 6. 6 - Instruction for Use/Handling
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 18/12/2003 and displayed until 04/04/2006
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 11/12/2003 and displayed until 18/12/2003
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 01/12/2003 and displayed until 11/12/2003
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|
